Prulifloxacin, also known as NM-441, is an inhibitor of bacterial DNA gyrase used to treat urinary tract infections. Prulifloxacin is an oral fluoroquinolone with a broad in vitro activity spectrum against Gram positive and negative bacteria and among fluoroquinolones has the lowest power of inducing resistance. In vitro and in vivo studies have shown its clinical efficacy and pathogen eradication.
Properties:
Appearance & Physical State: Yellow or slightly yellow power
Density: 1.62 g/cm3
Boiling Point: 633.2ºC at 760 mmHg
Flash Point: 336.8ºC
Refractive Index: 1.698
Vapor Pressure: 1.77E-20mmHg at 25°C
COVID-19 inhibitor Related Products:
Dexamethasone; Carfilzomib; Ritonavir; Telaprevir; Lopinavir; PF-07321332; PF-00835231; Danoprevir; Baricitinib; Nafamostat; Lamivudine; Ivermectin; Azithromycin; Praziquantel; TDZD-8; Aloxistatin; Darunavir; Ledipasvir; Remdesivir; Velpatasvir; Boceprevir